Lu Daopei Hematology Hospital
Immunotherapy in China typically ranges from $2,800 to $8,500 depending on the protocol and cancer type. Final costs depend on the drug origin, cycle frequency, and hospital tier in cities like Beijing and Guangzhou. Patients save approximately 81% compared to the US, where costs average $30,000. Chinese packages often include advanced diagnostics and minimally invasive support therapies.
Bookimed Expert Insight: Choosing JCI-accredited centers in Guangzhou offers high-value alternatives to standard chemotherapy. Fuda Cancer Hospital provides packages around $4,900 that integrate immunotherapy with NanoKnife and cryosurgery. This multi-modal approach is a smart move for late-stage cases. It often yields better results than monotherapy alone. Hospitals like Lu Daopei in Beijing also offer massive scale with 1,300 beds for specialized hematology care.
| China | Turkey | Austria | |
| Immunotherapy | from $2,800 | from $2,200 | from $30,000 |
| Sarcoma Immunotherapy | from $11,200 | from $18,000 | from $60,000 |
| Immunotherapy for prostate cancer | from $19,500 | from $12,000 | from $30,000 |
| Immunotherapy for lung cancer | from $4,200 | from $18,000 | from $30,000 |
| Immunotherapy for breast cancer | from $22,500 | from $9,500 | from $35,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Immunotherapy upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunotherapy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunotherapy journey.
Day 1
Day 2
Day 3
Day 4
Day 5 to Day 7
Week 2
Week 3
Week 4
Please note that each patient"s case is unique and the above schedule can change depending on the patient"s health condition and response to the treatment.
Bookimed, a leading global medical tourism platform, is committed to helping clients looking for Immunotherapy in China by offering expert assistance and trustworthy medical solutions for every situation. Smart automatic ranking system is used to compose transparent clinic listings, meticulously maintained by a data scientist using AI for accuracy. The platform guarantees authenticity by publishing reviews from real patients after their treatments. Bookimed offers comprehensive medical solutions, with updates from clinics to ensure trustworthiness. The content about Immunotherapy in China, crafted by experienced medical authors and reviewed by specialists, adheres to Bookimed"s Editorial Guidelines, reflecting the platform"s commitment to delivering high-quality and clear health information. For more details or inquiries, feel free to contact us at marketing@bookimed.com or learn more about us and our mission here.
Professor Niu Lizhi is a renowned Chinese cancer doctor, President of Fuda Cancer Hospital, and expert in minimally invasive cryosurgery. He has performed over 10,000 cryosurgeries and 500 NanoKnife procedures, and is the author of over 100 papers in surgical oncology, cryosurgery, and NanoKnife. He is Vice-President of the Asian Society of Cryosurgery and the International Society of Cryosurgery, and a member of the Chinese Medication Association, the China Anti-Cancer Association, the International Hepato-Pancreato-Biliary Association, and the Chinese Society of Integrated Traditional Chinese and Western Medicine.
Written by Kateryna Zamkovska
Written by Kateryna Zamkovska
Written by Kateryna Zamkovska
When considering Immunotherapy, it’s important to understand the different techniques and which is best suited for you. Here’s a concise comparison of popular options:
Keytruda, a form of immune-based therapy, leverages the body's immune system to target and destroy cancer cells using monoclonal antibodies.
CAR T-cell therapy is a personalized immune system therapy that modifies a patient's T-cells to target and destroy cancer cells.